Protalix BioTherapeutics Inc. (DE)

News & Events

Press Releases

In The Media

1. Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

   PR Newswire MAY 14, 2025 6:50 AM EDT
   Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Confere...
   READ ARTICLE

2. Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

   PR Newswire MAY 9, 2025 6:50 AM EDT
   Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results PR N...
   READ ARTICLE

3. Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

   PR Newswire MAY 5, 2025 6:50 AM EDT
   Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, ...
   READ ARTICLE

4. Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

   PR Newswire MAR 24, 2025 6:50 AM EDT
   Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 202...
   READ ARTICLE

5. iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025

   ACCESS Newswire MAR 21, 2025 9:00 AM EDT
   RALEIGH, NC / ACCESS Newswire / March 21, 2025 / iAccess Alpha's Virtual Best Ideas Spring In...
   READ ARTICLE

6. Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

   PR Newswire MAR 17, 2025 6:50 AM EDT
   Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results PR New...
   READ ARTICLE

7. Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025

   PR Newswire MAR 10, 2025 6:50 AM EDT
   Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17,...
   READ ARTICLE

8. Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference

   PR Newswire FEB 4, 2025 6:50 AM EST
   Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference P...
   READ ARTICLE

9. Protalix BioTherapeutics Issues 2025 Letter to Stockholders

   PR Newswire DEC 23, 2024 6:50 AM EST
   Protalix BioTherapeutics Issues 2025 Letter to Stockholders PR Newswire CARMI...
   READ ARTICLE

10. Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa

    PR Newswire DEC 9, 2024 6:30 AM EST
    Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submiss...
    READ ARTICLE